The ORVAC trial protocol: A phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis

Bianca Fleur Middleton, Mark A. Jones, Claire S. Waddington, Margaret Danchin, Carly McCallum, Sarah Gallagher, Amanda Jane Leach, Ross Andrews, Carl Kirkwood, Nigel Cunliffe, Jonathan Carapetis, Julie A. Marsh, Tom Snelling

Research output: Contribution to journalArticlepeer-review

55 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The ORVAC trial protocol: A phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis'. Together they form a unique fingerprint.

Medicine and Dentistry